Benjamin Griffiths
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Benjamin Griffiths has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
Daniel Peckham
Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK
1 shared publication- Ian J. Clifton
Department of Respiratory Medicine, Leeds Teaching Hospitals NHS Trust, Leeds, UK
1 shared publication - Oliver J. Price
School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK
1 shared publication Rebecca J. Birch
Leeds Institute of Medical Research, University of Leeds, Leeds, UK
1 shared publicationReem Alajmi
School of Biomedical Sciences, Faculty of Biological Sciences, University of Leeds, Leeds, UK
1 shared publication
Latest Publications
- Open Access
- 1 January 2026
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 35 (179) , 250165
Physical inactivity in chronic airways disease: an important candidate in the treatable traits paradigm
Background: Physical inactivity is a common and potentially modifiable trait in individuals with chronic airways disease, yet disease-specific physical activity profiles and clinical determinants remain poorly defined. Methods: We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines to characterise physical activity profiles across the spectrum of chronic airways disease. Studies reporting objectively measured physical activity in adults with COPD, asthma, noncystic fibrosis bronchiectasis, cystic fibrosis or primary ciliary dyskinesia were included. Primary outcomes were daily step count and time spent in moderate-to-vigorous physical activity (MVPA). Univariate and multivariate regression analysis was used to explore disease-specific determinants and associations with established clinical outcome measures. Results: 236 studies (353 cohorts, n=25 278 with chronic airways disease) met the eligibility criteria. The mean daily step count was 5494 (95% CI 5152–5636) and MVPA was 48.2 min·day −1 (95% CI 33.8–62.6), with the lowest levels observed in COPD. Physical activity levels were consistently lower than matched healthy controls. Disease-specific determinants of physical activity remained elusive; body mass index and percent predicted forced expiratory volume in 1 s (FEV 1 ) were significant in COPD and asthma. Step count associated positively with FEV 1 % pred and 6-min walk distance, and negatively with modified Medical Research Council scores. Conclusion: Physical inactivity is highly prevalent across chronic airways diseases and is consistently associated with established clinical outcome measures. These findings highlight the clinical relevance of objective physical activity assessment and support its consideration within the treatable traits framework as part of routine disease evaluation and management.
- 1 January 2026
- Published by European Respiratory Society (ERS) in European Respiratory Review
- Vol. 35 (179) , 250165
Open AccessPhysical inactivity in chronic airways disease: an important candidate in the treatable traits paradigm
Background: Physical inactivity is a common and potentially modifiable trait in individuals with chronic airways disease, yet disease-specific physical activity profiles and clinical determinants remain poorly defined. Methods: We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines to characterise physical activity profiles across the spectrum of chronic airways disease. Studies reporting objectively measured physical activity in adults with COPD, asthma, noncystic fibrosis bronchiectasis, cystic fibrosis or primary ciliary dyskinesia were included. Primary outcomes were daily step count and time spent in moderate-to-vigorous physical activity (MVPA). Univariate and multivariate regression analysis was used to explore disease-specific determinants and associations with established clinical outcome measures. Results: 236 studies (353 cohorts, n=25 278 with chronic airways disease) met the eligibility criteria. The mean daily step count was 5494 (95% CI 5152–5636) and MVPA was 48.2 min·day −1 (95% CI 33.8–62.6), with the lowest levels observed in COPD. Physical activity levels were consistently lower than matched healthy controls. Disease-specific determinants of physical activity remained elusive; body mass index and percent predicted forced expiratory volume in 1 s (FEV 1 ) were significant in COPD and asthma. Step count associated positively with FEV 1 % pred and 6-min walk distance, and negatively with modified Medical Research Council scores. Conclusion: Physical inactivity is highly prevalent across chronic airways diseases and is consistently associated with established clinical outcome measures. These findings highlight the clinical relevance of objective physical activity assessment and support its consideration within the treatable traits framework as part of routine disease evaluation and management.